Maroz Natallia, Mohandes Samer, Field Halle, Kabakov Zlata, Simman Richard
Renal Physicians Inc., Dayton, OH, USA ; Department of Medicine, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA.
Department of Medicine, Wright State University, Boonshoft School of Medicine, Dayton, OH, USA ; Miamy Valley Hospital, Dayton, OH, USA.
J Am Coll Clin Wound Spec. 2015 Aug 7;6(1-2):24-8. doi: 10.1016/j.jccw.2015.08.002. eCollection 2014 Apr.
Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a devastating disease typically seen in patients with end stage renal disease. It manifests as extremely painful symmetrical wounds resistant to surgical and medical interventions. The prevalence of CUA among hemodialysis dependent patients was found to be as high as 4.1%. The management of patients with CUA requires a multidisciplinary approach by the medical team, yet often results in a low rate of successful outcomes. Recently, non-uremic calciphylaxis (NUC) has been described in the absence of kidney disease. Limited knowledge exists on the management of NUC and the outcomes of this condition. Herein we describe three clinical scenarios of patients diagnosed with NUC in the absence of permanent or prolonged acute renal pathology. The reporting of successful and fruitless therapeutic interventions for wound management in NUC is important for compiling the evidence of effective therapeutic strategies.
钙化性尿毒症小动脉病(CUA),也称为钙化防御,是一种典型见于终末期肾病患者的毁灭性疾病。它表现为对手术和药物干预均有抵抗的极其疼痛的对称性伤口。在依赖血液透析的患者中,CUA的患病率高达4.1%。CUA患者的管理需要医疗团队采取多学科方法,但往往成功率较低。最近,在无肾脏疾病的情况下描述了非尿毒症性钙化防御(NUC)。关于NUC的管理及这种情况的预后,目前了解有限。在此,我们描述了3例在无永久性或长期急性肾脏病变情况下被诊断为NUC的患者的临床病例。报告NUC伤口管理中成功和无效的治疗干预措施对于汇编有效治疗策略的证据很重要。